Continuous vs bolus administration of imipenem in critically ill patients with ICU-acquired pneumonia

Por Sakka, S, Glauner, A, Bulitta, J, Kinzig-Schippers, M, Sörgel, F
Publicado em 2004

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

Por Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Publicado em 2009

ABT-773: Pharmacokinetics and Interactions with Ranitidine and Sucralfate

Por Pletz, M. W., Preechachatchaval, V., Bulitta, J., Allewelt, M., Burkhardt, O., Lode, H.
Publicado em 2003

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

Por Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicado em 2011

Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers

Por Bulitta, J. B., Duffull, S. B., Kinzig-Schippers, M., Holzgrabe, U., Stephan, U., Drusano, G. L., Sörgel, F.
Publicado em 2007

Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Co...

Por Prokocimer, P., Bien, P., Surber, J., Mehra, P., DeAnda, C., Bulitta, J. B., Corey, G. R.
Publicado em 2011

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach

Por Garonzik, Samira M., Lenhard, Justin R., Forrest, Alan, Holden, Patricia N., Bulitta, Jϋrgen B., Tsuji, Brian T.
Publicado no PLoS One (2016)

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

Por Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Publicado em 2010